Correction to: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England (Nature Communications, (2024), 15, 1, (3822), 10.1038/s41467-024-47745-z)
Copland E. et al, (2024), Nature Communications, 15
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Copland E. et al, (2024), Nature Communications, 15
Effectiveness and safety of COVID-19 vaccination in people with blood cancer
Copland E. et al, (2024), European Journal of Cancer, 201
blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and mendelian randomisation studies
Nazarzadeh M. et al, (2024), EUROPEAN HEART JOURNAL, 45
Establishing the QResearch Pregnancy Register in the QResearch® database: methods and cohort description
Snelling AJHL. et al, (2024)
Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis
Wamil M. et al, (2023), Scientific Reports, 13
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis
Bidel Z. et al, (2023), Hypertension, 80, 2293 - 2302
Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England
Hirst J. et al, (2023), European Journal of Cancer, 183, 162 - 170
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Nazarzadeh M. et al, (2022), The Lancet Diabetes and Endocrinology, 10, 645 - 654
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Canoy D. et al, (2022), Current Cardiology Reports, 24, 851 - 860
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports
Nazarzadeh M. et al, (2022), Journal of Hypertension, 40, 847 - 852
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
Canoy D. et al, (2022), Heart, 108, 1281 - 1289
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
Nazarzadeh M. et al, (2021), The Lancet, 398, 1803 - 1810
Blood pressure treatment: how low should you go? – Authors' reply
Rahimi K. et al, (2021), The Lancet, 398, 1684 - 1685
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
Nazarzadeh M. et al, (2021), The Lancet, 398, 1803 - 1810
Blood pressure treatment: how low should you go? – Authors' reply
Rahimi K. et al, (2021), The Lancet, 398, 1684 - 1685
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Rahimi K. et al, (2021), The Lancet, 398, 1053 - 1064